Get the Stockscreener App
2.665
1.48%
-0.045
Gain Therapeutics Inc stock is traded at $2.665, with a volume of 211.51K.
It is down -1.48% in the last 24 hours and up +47.51% over the past month.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
See More
Previous Close:
$2.71
Open:
$2.67
24h Volume:
211.51K
Relative Volume:
0.17
Market Cap:
$102.31M
Revenue:
$210.70K
Net Income/Loss:
$-21.37M
P/E Ratio:
-2.4227
EPS:
-1.1
Net Cash Flow:
$-21.10M
1W Performance:
-2.55%
1M Performance:
+47.51%
6M Performance:
+39.06%
1Y Performance:
+36.92%
1-Day Range:
$2.52
$2.697
1-Week Range:
$2.36
$2.79
52-Week Range:
$1.41
$4.34
Gain Therapeutics Inc Stock (GANX) Company Profile
Name
Gain Therapeutics Inc
Sector
Industry
Phone
(301) 500-1556
Address
4800 HAMPDEN LANE, BETHESDA
Compare GANX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
2.6601 | 104.23M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.97 | 123.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
778.77 | 83.60B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
754.50 | 46.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
321.89 | 43.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
295.06 | 34.79B | 4.98B | 69.60M | 525.67M | 0.5198 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Dec-06-24 | Initiated | ROTH MKM | Buy |
| Aug-14-24 | Resumed | Oppenheimer | Outperform |
| Apr-12-21 | Initiated | BTIG Research | Buy |
| Apr-12-21 | Initiated | Oppenheimer | Outperform |
Gain Therapeutics Inc Stock (GANX) Latest News
GANX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
GANX PE Ratio & Valuation, Is GANX Overvalued - Intellectia AI
Gain Therapeutics to Present Key Clinical Program Updates at Oppenheimer Conference - AD HOC NEWS
Nasdaq Gains Over 1%; Keurig Dr Pepper Earnings Top Views - Benzinga
Gain Therapeutics, Inc. (NASDAQ:GANX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference - 富途牛牛
What’s the beta of Gain Therapeutics Inc. stock2025 Short Interest & Detailed Earnings Play Alerts - mfd.ru
What’s the analyst consensus on Gain Therapeutics Inc.Weekly Trade Review & Risk Controlled Swing Alerts - mfd.ru
Can Gain Therapeutics Inc. stock double in the next yearBreakout Watch & Weekly High Return Forecasts - mfd.ru
Aug Summary: Is Gain Therapeutics Inc stock a falling knife or bargain buyJuly 2025 Technicals & Growth-Oriented Investment Plans - baoquankhu1.vn
Gain Therapeutics plans fireside chat at Oppenheimer healthcare event - Stock Titan
What dividend safety score for Gain Therapeutics Inc. stockWeekly Profit Analysis & High Accuracy Trade Alerts - mfd.ru
Market Fear: Is Gain Therapeutics Inc a strong candidate for buy and holdAnalyst Upgrade & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Gain Therapeutics, Inc. (NASDAQ:GANX) Short Interest Up 19.9% in January - MarketBeat
Published on: 2026-02-16 00:03:51 - mfd.ru
Is Gain Therapeutics Inc. benefiting from innovation trendsJuly 2025 Sentiment & Fast Entry High Yield Stock Tips - mfd.ru
Will Edgewise Therapeutics Inc. stock gain from government policies2025 Fundamental Recap & Reliable Entry Point Trade Alerts - mfd.ru
Insider Trends: Whats the beta of Themes Etf Trust Leverage Shares 2x Long Panw Daily Etf stockPortfolio Gains Report & Safe Entry Trade Signal Reports - baoquankhu1.vn
Aug Wrap: Whats the analyst consensus on Gain Therapeutics IncJobs Report & Risk Managed Investment Signals - baoquankhu1.vn
Will Entrada Therapeutics Inc. stock gain from lower inflationJuly 2025 Patterns & Long-Term Capital Growth Ideas - mfd.ru
GANX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Can Gain Therapeutics Inc. continue delivering strong returnsJuly 2025 Short Interest & AI Forecasted Entry/Exit Points - mfd.ru
Critical Contrast: Gain Therapeutics (NASDAQ:GANX) and Ionis Pharmaceuticals (NASDAQ:IONS) - Defense World
Gain Therapeutics, Inc Advances Parkinson's Treatment to Phase 2 - TradingView
Treasury Yields: What hedge funds are buying Gain Therapeutics IncMarket Growth Report & Long-Term Safe Return Strategies - baoquankhu1.vn
Can Gain Therapeutics Inc. outperform in the next rallyCPI Data & Safe Swing Trade Setup Alerts - mfd.ru
Smart Money: Is Gain Therapeutics Inc part of any major index2025 Buyback Activity & Risk Controlled Daily Plans - baoquankhu1.vn
Is Pediatrix Medical Group Inc. stock undervalued right nowJuly 2025 Breakouts & Technical Confirmation Alerts - baoquankhu1.vn
Published on: 2026-01-31 20:42:39 - baoquankhu1.vn
Wall Street Recap: Can Gain Therapeutics Inc outperform in the next rallyTrade Performance Summary & Long-Term Growth Portfolio Plans - baoquankhu1.vn
What CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) 35% Share Price Gain Is Not Telling You - simplywall.st
Gain Therapeutics, Inc. (NASDAQ:GANX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
5 Investigational Therapies That Could Change the Parkinson’s Landscape - BioSpace
Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Bond Watch: Will Atlantica Sustainable Infrastructure plc stock benefit from M AMarket Growth Review & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Aug Final Week: Should I average down on Gain Therapeutics Inc stockNew Guidance & Safe Entry Trade Signal Reports - baoquankhu1.vn
Can Gain Therapeutics Inc. stock attract ESG capital inflowsVolatility Adjusted Trading & Free Stay Informed With Forecasts - Bollywood Helpline
Short Interest in Gain Therapeutics, Inc. (NASDAQ:GANX) Rises By 28.6% - MarketBeat
Aug PreEarnings: Can Gain Therapeutics Inc continue delivering strong returnsJuly 2025 Action & Low Volatility Stock Recommendations - baoquankhu1.vn
Exit Recap: Is Gain Therapeutics Inc attractive for institutional investors2025 Breakouts & Breakdowns & Weekly Watchlist of Top Performers - baoquankhu1.vn
Wall Street Recap: Is Gain Therapeutics Inc trading at a discountWeekly Earnings Recap & Consistent Profit Trading Strategies - baoquankhu1.vn
Pullback Watch: What is Gain Therapeutics Incs 5 year growth outlookTrade Volume Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Movement Recap: Can Gain Therapeutics Inc outperform in the next rallyJuly 2025 Spike Watch & Free Verified High Yield Trade Plans - baoquankhu1.vn
Aug Fed Impact: Whats the beta of Gain Therapeutics Inc stockMarket Activity Recap & Fast Entry and Exit Trade Plans - baoquankhu1.vn
EPS Watch: Whats the beta of Gain Therapeutics Inc stock2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Aug Intraday: What is Gain Therapeutics Incs TAM Total Addressable MarketJuly 2025 Breakouts & Daily Profit Focused Stock Screening - baoquankhu1.vn
Why Gain Therapeutics Inc. stock could see breakout soonQuarterly Risk Review & Free Technical Pattern Based Buy Signals - Улправда
Gain Therapeutics Shares Early Phase 1b Data: GT-02287 Shows UPDRS Gains, Key PD Biomarker Drop - Defense World
Reviewing Aldeyra Therapeutics (NASDAQ:ALDX) & Gain Therapeutics (NASDAQ:GANX) - Defense World
How Ideal Power Inc. (5ILA) stock gains from tech spendingJuly 2025 Trade Ideas & Risk Controlled Swing Alerts - Улправда
Will Stoke Therapeutics Inc. stock gain from strong economyJuly 2025 Trends & Verified Short-Term Trading Plans - Улправда
Gain Therapeutics Inc Stock (GANX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.19%
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):